Bay Area scientists reported Monday that aspirin is proving to be a preventative breakthrough in an especially deadly common cancer — pancreatic cancer.
After being diagnosed, 95 percent of patients are dead in five years, but more than half die within six months.
Prof. Matthias Hebrok, a UCSF researcher told KTVU that his team’s remarkable discovery may help prevent this killer from getting started by reducing inflammation.
(READ the story at KTVU-Tv)